Andrew C. Pearce

3.2k total citations
37 papers, 2.4k citations indexed

About

Andrew C. Pearce is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew C. Pearce has authored 37 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 12 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew C. Pearce's work include Platelet Disorders and Treatments (17 papers), Cell Adhesion Molecules Research (7 papers) and Blood properties and coagulation (5 papers). Andrew C. Pearce is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Cell Adhesion Molecules Research (7 papers) and Blood properties and coagulation (5 papers). Andrew C. Pearce collaborates with scholars based in United Kingdom, United States and Germany. Andrew C. Pearce's co-authors include Steve P. Watson, Jocelyn M. Auger, Raymond A. Dwek, Holger Hebestreit, Peter Wonerow, Nicole Zitzmann, Ángel Galindo García, Katsue Suzuki‐Inoue, S. Prabhakar and Stefan Pöhlmann and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Andrew C. Pearce

37 papers receiving 2.3k citations

Peers

Andrew C. Pearce
Patrizia Marchese United States
Markus A. Riederer Switzerland
Corie N. Shrimpton United States
Hatem H. Salem Australia
Christopher Ocampo United States
Barbara R. Schwartz United States
Andrew C. Pearce
Citations per year, relative to Andrew C. Pearce Andrew C. Pearce (= 1×) peers Glenn Merrill‐Skoloff

Countries citing papers authored by Andrew C. Pearce

Since Specialization
Citations

This map shows the geographic impact of Andrew C. Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew C. Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew C. Pearce more than expected).

Fields of papers citing papers by Andrew C. Pearce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew C. Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew C. Pearce. The network helps show where Andrew C. Pearce may publish in the future.

Co-authorship network of co-authors of Andrew C. Pearce

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew C. Pearce. A scholar is included among the top collaborators of Andrew C. Pearce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew C. Pearce. Andrew C. Pearce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yu, Andrew C. Pearce, Simona Eleuteri, et al.. (2023). Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease mouse model. Nature Communications. 14(1). 7295–7295. 43 indexed citations
2.
Thorpe, James H., Kathrine J. Smith, Xiao Qing Lewell, et al.. (2019). Evaluation of a crystallographic surrogate for kallikrein 5 in the discovery of novel inhibitors for Netherton syndrome. Acta Crystallographica Section F Structural Biology Communications. 75(5). 385–391. 2 indexed citations
3.
Walker, Ann L., Alexis Denis, Ryan P. Bingham, et al.. (2019). Design and development of a series of borocycles as selective, covalent kallikrein 5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(20). 126675–126675. 6 indexed citations
4.
Gilbane, A, Emma Derrett‐Smith, Sarah L. Trinder, et al.. (2015). Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis. American Journal of Respiratory and Critical Care Medicine. 191(6). 665–677. 38 indexed citations
5.
Ciuclan, Loredana, Martin Hussey, Victoria J. Burton, et al.. (2013). Imatinib Attenuates Hypoxia-induced Pulmonary Arterial Hypertension Pathology via Reduction in 5-Hydroxytryptamine through Inhibition of Tryptophan Hydroxylase 1 Expression. American Journal of Respiratory and Critical Care Medicine. 187(1). 78–89. 55 indexed citations
6.
Jones, Peter Lloyd, Nicholas Duggan, Denise Head, et al.. (2013). An Inhibitor of NADPH Oxidase-4 Attenuates Established Pulmonary Fibrosis in a Rodent Disease Model. American Journal of Respiratory Cell and Molecular Biology. 50(1). 158–169. 96 indexed citations
7.
Jarvis, Gavin E., Dominique Bihan, Samir W. Hamaia, et al.. (2011). A role for adhesion and degranulation‐promoting adapter protein in collagen‐induced platelet activation mediated via integrin α2β1. Journal of Thrombosis and Haemostasis. 10(2). 268–277. 27 indexed citations
8.
Chagraoui, Hédia, Mira Kassouf, Nicolas Goardon, et al.. (2011). SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood. 118(3). 723–735. 34 indexed citations
9.
Howell, Katherine B., Joanne M. Chesson, Danielle I. Stanisic, et al.. (2008). PfEMP1 is the major target of antibodies to the surface of P-falciparum-infected erythrocytes that are associated with protection from malaria.. International Journal for Parasitology. 38. 1 indexed citations
10.
Hughes, Craig E., Jocelyn M. Auger, Jane McGlade, et al.. (2008). Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC‐2. Journal of Thrombosis and Haemostasis. 6(12). 2152–2159. 26 indexed citations
11.
Pears, Catherine J., Kelly Thornber, Jocelyn M. Auger, et al.. (2008). Differential Roles of the PKC Novel Isoforms, PKCδ and PKCε, in Mouse and Human Platelets. PLoS ONE. 3(11). e3793–e3793. 40 indexed citations
12.
Pearce, Andrew C., et al.. (2007). A young man with hyperimmunoglobulin-E syndrome and IgA and IgG deficiencies. Clinical and Experimental Dermatology. 32(4). 391–394. 2 indexed citations
13.
Calaminus, Simon D. J., Owen J. T. McCarty, Jocelyn M. Auger, et al.. (2007). A major role for Scar/WAVE‐1 downstream of GPVI in platelets. Journal of Thrombosis and Haemostasis. 5(3). 535–541. 22 indexed citations
14.
Williams, Jennifer A. E., Michael G. Tomlinson, Johannes A. Eble, et al.. (2007). The C-type Lectin Receptors CLEC-2 and Dectin-1, but Not DC-SIGN, Signal via a Novel YXXL-dependent Signaling Cascade. Journal of Biological Chemistry. 282(17). 12397–12409. 173 indexed citations
15.
Williams, Jennifer A. E., Michael G. Tomlinson, Johannes A. Eble, et al.. (2007). The C-type Lectin Receptors CLEC-2 and Dectin-1, but Not DC-SIGN, Signal via a Novel YXXL-dependent. 1 indexed citations
16.
Senis, Yotis A., Ben Atkinson, Andrew C. Pearce, et al.. (2005). Role of the p110δ PI 3-kinase in integrin and ITAM receptor signalling in platelets. Platelets. 16(3-4). 191–202. 40 indexed citations
17.
Collins, S.M., et al.. (2005). Environmental radioactivity comparison exercise 2005.. 7 indexed citations
18.
Pearce, Andrew C., Yotis A. Senis, Daniel D. Billadeau, et al.. (2004). Vav1 and Vav3 Have Critical but Redundant Roles in Mediating Platelet Activation by Collagen. Journal of Biological Chemistry. 279(52). 53955–53962. 80 indexed citations
19.
García, Ángel Galindo, S. Prabhakar, Andrew C. Pearce, et al.. (2004). Extensive analysis of the human platelet proteome by two‐dimensional gel electrophoresis and mass spectrometry. PROTEOMICS. 4(3). 656–668. 126 indexed citations
20.
Wonerow, Peter, Andrew C. Pearce, David J. Vaux, & Steve P. Watson. (2003). A Critical Role for Phospholipase Cγ2 in αIIbβ3-mediated Platelet Spreading. Journal of Biological Chemistry. 278(39). 37520–37529. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026